Mapping the immune landscape of ovarian tumors to predict outcomes

Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer

NIH-funded research Children's Mercy Hosp (Kansas City, Mo) · NIH-11314490

This project uses advanced tumor imaging and new statistical models to map immune cells in ovarian tumors and help predict survival for women with ovarian cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionChildren's Mercy Hosp (Kansas City, Mo) NIH-funded
Lab location1 site (Kansas City, United States)
Project IDNIH-11314490 on NIH RePORTER

What this research studies

Researchers are building new statistical methods and software to analyze multiplex immunofluorescence images that show where immune cells sit inside ovarian tumors. They will develop spatial approaches and Bayesian models that handle the patchy, zero-heavy counts of immune cells and the tissue architecture. These tools will be applied to existing tumor imaging data from about 2,500 women with epithelial ovarian cancer enrolled in established studies. The team aims to create an "Oimmuno" immunoscore that links the tumor immune landscape to survival outcomes.

Who could benefit from this research

Good fit: Women with epithelial ovarian cancer—especially those who have tumor tissue available for immune imaging or who are part of the contributing research cohorts—are the ideal candidates to benefit from this work.

Not a fit: People without epithelial ovarian cancer or those who do not have tumor tissue available for imaging would not be expected to benefit directly from this project.

Why it matters

Potential benefit: If successful, this work could produce an immunoscore that helps doctors better predict prognosis and guide treatment decisions for women with ovarian cancer.

How similar studies have performed: Spatial immune profiling and immunoscores have shown promise in other cancers, but applying large-scale spatial Bayesian modeling to ovarian cancer is relatively novel.

Where this research is happening

Kansas City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.